181 related articles for article (PubMed ID: 34322587)
1. Functionalized non-viral cationic vectors for effective siRNA induced cancer therapy.
Gupta K; Puri A; Shapiro BA
DNA RNA Nanotechnol; 2017 May; 4(1):1-20. PubMed ID: 34322587
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy.
Mousazadeh H; Pilehvar-Soltanahmadi Y; Dadashpour M; Zarghami N
J Control Release; 2021 Feb; 330():1046-1070. PubMed ID: 33188829
[TBL] [Abstract][Full Text] [Related]
3. Cellular Delivery of siRNAs Using Bolaamphiphiles.
Gupta K
Methods Mol Biol; 2017; 1632():187-205. PubMed ID: 28730440
[TBL] [Abstract][Full Text] [Related]
4. Cationic lipids and polymers mediated vectors for delivery of siRNA.
Zhang S; Zhao B; Jiang H; Wang B; Ma B
J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
[TBL] [Abstract][Full Text] [Related]
5. Current Development of siRNA Bioconjugates: From Research to the Clinic.
Chernikov IV; Vlassov VV; Chernolovskaya EL
Front Pharmacol; 2019; 10():444. PubMed ID: 31105570
[TBL] [Abstract][Full Text] [Related]
6. [Current status of non-viral vectors for siRNA delivery].
Yang FF; Huang W; Li YF; Gao ZG
Yao Xue Xue Bao; 2011 Dec; 46(12):1436-43. PubMed ID: 22375415
[TBL] [Abstract][Full Text] [Related]
7. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes.
Wang J; Chen G; Liu N; Han X; Zhao F; Zhang L; Chen P
Adv Colloid Interface Sci; 2022 Apr; 302():102638. PubMed ID: 35299136
[TBL] [Abstract][Full Text] [Related]
8. Peptides used in the delivery of small noncoding RNA.
Shukla RS; Qin B; Cheng K
Mol Pharm; 2014 Oct; 11(10):3395-408. PubMed ID: 25157701
[TBL] [Abstract][Full Text] [Related]
9. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
10. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
11. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
12. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy.
Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC
J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808
[TBL] [Abstract][Full Text] [Related]
13. Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus.
Sohrab SS; El-Kafrawy SA; Mirza Z; Kamal MA; Azhar EI
Curr Pharm Des; 2018; 24(1):62-77. PubMed ID: 29119921
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances of Polycationic siRNA Vectors for Cancer Therapy.
Bholakant R; Qian H; Zhang J; Huang X; Huang D; Feijen J; Zhong Y; Chen W
Biomacromolecules; 2020 Aug; 21(8):2966-2982. PubMed ID: 32568525
[TBL] [Abstract][Full Text] [Related]
15. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
16. Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.
Liu F; Wang C; Gao Y; Li X; Tian F; Zhang Y; Fu M; Li P; Wang Y; Wang F
Mol Diagn Ther; 2018 Oct; 22(5):551-569. PubMed ID: 29926308
[TBL] [Abstract][Full Text] [Related]
17. Folate Receptor-Mediated siRNA Delivery: Recent Developments and Future Directions for RNAi Therapeutics.
Gangopadhyay S; Nikam RR; Gore KR
Nucleic Acid Ther; 2021 Aug; 31(4):245-270. PubMed ID: 33595381
[TBL] [Abstract][Full Text] [Related]
18. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
19. Strategies, design, and chemistry in siRNA delivery systems.
Dong Y; Siegwart DJ; Anderson DG
Adv Drug Deliv Rev; 2019 Apr; 144():133-147. PubMed ID: 31102606
[TBL] [Abstract][Full Text] [Related]
20. Charge-reversal lipids, peptide-based lipids, and nucleoside-based lipids for gene delivery.
LaManna CM; Lusic H; Camplo M; McIntosh TJ; Barthélémy P; Grinstaff MW
Acc Chem Res; 2012 Jul; 45(7):1026-38. PubMed ID: 22439686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
